Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22,291 | 12 | 42.8% |
| Consulting Fee | $9,930 | 6 | 19.1% |
| Unspecified | $9,030 | 4 | 17.4% |
| Food and Beverage | $7,434 | 299 | 14.3% |
| Travel and Lodging | $2,405 | 4 | 4.6% |
| Education | $372.34 | 16 | 0.7% |
| Honoraria | $350.00 | 1 | 0.7% |
| Grant | $220.00 | 1 | 0.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | $16,766 | 36 | $0 (2024) |
| ABBVIE INC. | $10,082 | 44 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $9,502 | 9 | $0 (2018) |
| Promius Pharma LLC | $8,336 | 25 | $0 (2019) |
| UCB, Inc. | $1,248 | 4 | $0 (2024) |
| Medimetriks Pharmaceuticals, Inc. | $1,058 | 4 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $754.49 | 34 | $0 (2024) |
| GENZYME CORPORATION | $546.13 | 14 | $0 (2024) |
| PFIZER INC. | $486.21 | 22 | $0 (2024) |
| Biofrontera Inc. | $480.01 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,780 | 46 | SUN PHARMACEUTICAL INDUSTRIES INC. ($6,608) |
| 2023 | $10,146 | 40 | Sun Pharmaceutical Industries Inc. ($9,334) |
| 2022 | $2,230 | 27 | UCB, Inc. ($1,204) |
| 2021 | $667.92 | 15 | Medimetriks Pharmaceuticals, Inc. ($350.00) |
| 2020 | $317.54 | 13 | Sun Pharmaceutical Industries Inc. ($187.47) |
| 2019 | $2,972 | 33 | Promius Pharma LLC ($2,124) |
| 2018 | $18,173 | 69 | Ortho Dermatologics, a division of Bausch Health US, LLC ($9,502) |
| 2017 | $9,747 | 100 | AbbVie, Inc. ($4,393) |
All Payment Transactions
343 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Immunology | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Immunology | ||||||
| 11/13/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: Dermatology | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Dermatology | ||||||
| 11/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Immunology | ||||||
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.34 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Immunology | ||||||
| 09/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $40.33 | General |
| Category: Immunology | ||||||
| 09/20/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Dermatology | ||||||
| 09/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.89 | General |
| Category: IMMUNOLOGY | ||||||
| 09/06/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Dermatology | ||||||
| 09/05/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $18.98 | General |
| 08/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: DERMATOLOGY | ||||||
| 08/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.48 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/20/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: Immunology | ||||||
| 08/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: Immunology | ||||||
| 08/06/2024 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 08/02/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Dermatology | ||||||
| 08/01/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: IMMUNOLOGY | ||||||
| 07/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Immunology | ||||||
| 07/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.61 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| P10-023 | AbbVie, Inc. | $9,030 | 4 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 5,431 | 15,659 | $2.1M | $1.1M |
| 2022 | 30 | 5,555 | 17,617 | $2.4M | $1.2M |
| 2021 | 28 | 5,821 | 12,900 | $1.5M | $684,684 |
| 2020 | 27 | 5,425 | 12,247 | $1.4M | $626,318 |
All Medicare Procedures & Services
112 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3245 | Injection, tildrakizumab, 1 mg | Office | 2023 | 14 | 4,400 | $869,000 | $481,625 | 55.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 548 | 1,140 | $393,300 | $148,059 | 37.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 642 | 1,046 | $158,961 | $86,765 | 54.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 638 | 928 | $139,200 | $52,459 | 37.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 700 | 1,012 | $63,240 | $42,760 | 67.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 446 | 579 | $57,657 | $37,847 | 65.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 348 | 868 | $72,912 | $36,176 | 49.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 171 | 260 | $69,371 | $31,388 | 45.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 595 | 821 | $91,566 | $29,247 | 31.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 488 | 3,576 | $50,064 | $19,065 | 38.1% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 88 | 113 | $32,151 | $17,921 | 55.7% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 84 | 116 | $30,003 | $15,105 | 50.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 94 | $13,751 | $8,510 | 61.9% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 42 | 49 | $12,999 | $7,027 | 54.1% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 48 | 51 | $12,635 | $6,455 | 51.1% |
| 10061 | Complicated or multiple drainage of skin abscess | Office | 2023 | 29 | 32 | $10,103 | $5,478 | 54.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 65 | 65 | $9,688 | $4,650 | 48.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 98 | 98 | $10,029 | $4,548 | 45.3% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 36 | 37 | $6,589 | $3,214 | 48.8% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 25 | 32 | $6,337 | $2,959 | 46.7% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 78 | 95 | $8,870 | $2,822 | 31.8% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 19 | 20 | $4,532 | $2,128 | 47.0% |
| 69100 | Biopsy of ear | Office | 2023 | 40 | 41 | $5,708 | $2,089 | 36.6% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 14 | 14 | $2,745 | $1,490 | 54.3% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 13 | 13 | $2,414 | $1,364 | 56.5% |
About Dr. Robert Sarro, MD
Dr. Robert Sarro, MD is a Dermatology healthcare provider based in Boca Raton, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1164403192.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Sarro, MD has received a total of $52,032 in payments from pharmaceutical and medical device companies, with $7,780 received in 2024. These payments were reported across 343 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($22,291).
As a Medicare-enrolled provider, Sarro has provided services to 22,232 Medicare beneficiaries, totaling 58,423 services with total Medicare billing of $3.5M. Data is available for 4 years (2020–2023), covering 112 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Boca Raton, FL
- Active Since 11/08/2005
- Last Updated 12/07/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1164403192
Products in Payments
- ILUMYA (Biological) $16,349
- SILIQ (Drug) $9,347
- Humira (Biological) $9,346
- Sernivo Spray 120ml (Drug) $3,157
- Trianex (Drug) $2,120
- Promiseb Complete (Device) $2,000
- Cloderm Cream (Drug) $934.87
- DUPIXENT (Biological) $877.89
- COSENTYX (Biological) $648.49
- Ameluz (Drug) $480.01
- EUCRISA (Drug) $370.94
- Genadur (Medical Supply) $350.00
- Neo-Synalar (Drug) $350.00
- Nicadan (Drug) $350.00
- RINVOQ (Biological) $299.01
- TREMFYA (Drug) $244.61
- Acticlate (Drug) $167.56
- XTRAC (Device) $158.30
- SOOLANTRA (Drug) $157.86
- TALTZ (Drug) $152.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Boca Raton
Dr. Jordana Herschthal, M.d, M.D
Dermatology — Payments: $184,324
Ann Reed, D.o, D.O
Dermatology — Payments: $65,597
Richard Greene
Dermatology — Payments: $63,360
David Herschthal, Md, MD
Dermatology — Payments: $25,556
Jodi Fiedler, M.d, M.D
Dermatology — Payments: $16,582
Shari Topper, Md, MD
Dermatology — Payments: $13,851